Nitric oxide synthase gene therapy for erectile dysfunction: comparison of plasmid, adenovirus, and adenovirus-transduced myoblast vectors.

MLA

Tirney, S., et al. “Nitric Oxide Synthase Gene Therapy for Erectile Dysfunction: Comparison of Plasmid, Adenovirus, and Adenovirus-Transduced Myoblast Vectors.” Molecular Urology, vol. 5, no. 1, Spring 2001, pp. 37–43. EBSCOhost, https://doi.org/10.1089/109153601750124302.

APA

Tirney, S., Mattes, C. E., Yoshimura, N., Yokayama, T., Ozawa, H., Tzeng, E., Birder, L. A., Kanai, A. J., Huard, J., de Groat, W. C., & Chancellor, M. B. (2001). Nitric oxide synthase gene therapy for erectile dysfunction: comparison of plasmid, adenovirus, and adenovirus-transduced myoblast vectors. Molecular Urology, 5(1), 37–43. https://doi.org/10.1089/109153601750124302

Chicago

Tirney, S, C E Mattes, N Yoshimura, T Yokayama, H Ozawa, E Tzeng, L A Birder, et al. 2001. “Nitric Oxide Synthase Gene Therapy for Erectile Dysfunction: Comparison of Plasmid, Adenovirus, and Adenovirus-Transduced Myoblast Vectors.” Molecular Urology 5 (1): 37–43. doi:10.1089/109153601750124302.